Carbapenemase-producing Gram-negative Microorganisms: Detection, Epidemiology and Therapeutic Challanges, ESCMID Postgraduate Education Course
1 - 2 December 2011, Athens, Greece
Organisers
Hellenic Society for Chemotherapy and the Hellenic National School of Public Health
Course Materials
Presentations are available for ESCMID members exclusively. Please log in or register.
Thursday, 1 December 2011
I. Classification and Epidemiology of Carbapenemases | |
---|---|
08:45–09:15 | Introduction to beta-lactamases. Irene Galani (GR) |
09:15–10:00 | Classification and hydrolytic activity of carbapenemases. Vivi Miriagou (GR) |
10:00–10:45 | Genetic structures at the origin of acquisition of the carbapenemase genes. Laurent Poirel (FR) |
II. Laboratory Issues | |||
---|---|---|---|
11:30–12:00 | When to suspect the presence of carbapenemases. Methods for phenotypic detection. Athanassios Tsakris (GR) | ||
12:00–12:30 | The rationale behind the EUCAST susceptibility breakpoints and new expert rules for carbapenems. Rafael Canton (ES) | ||
12:30–13:00 | How to effectively report laboratory findings to clinicians (Breakpoints and Interpretation). Alkis Vatopoulos (GR) |
III. Carbapenemase-Producing Bacteria: International Experience | |
---|---|
14:00–14:30 | The European experience on carbapenemases. Gian Maria Rossolini (IT) |
14:30–15:00 | The Israeli and USA experience on carbapenemases. Yehuda Carmeli (IL) |
15:00–15:30 | The Greek experience on carbapenemases. Maria Souli (GR) |
Friday, 2 December 2011
IV. Therapeutic Challenges | |
---|---|
09:00–09:30 | Carbapenemase-producing Enterobacteriaceae with low-level resistance to carbapenems: Do we have more treatment options? George L. Daikos (GR) |
09:30–10:00 | Colistin in the treatment of infections by carbapenemase-producing bacteria. Diamantis Plachouras (GR) |
10:00–10:30 | Tigecycline in the treatment of infections by carbapenemase-producing bacteria. Garyphallia Poulakou (GR) |
10:30–11:00 | Fosfomycin in the treatment of infections by carbapenemase-producing bacteria. Helen Giamarellou (GR) |
V. Laboratory Rounds and Case Presentations | |
---|---|
12:45–13:45 | Case Presentations: From the agar plate to the patient Anastasia Antoniadou (GR) & George L. Daikos (GR) |
VI. Prevention and Control | |
---|---|
14:30–15:00 | Infection control issues. Anastasia Antoniadou (GR) |
15:00–15:30 | Focusing on antibiotic stewardship. Helen Giamarellou (GR) |
Course Faculty
- Anastasia Antoniadou, Athens, GR
- Rafael Canton, Madrid, ES
- Yehuda Carmeli, Tel Aviv, IL
- George L. Daikos, Athens, GR
- Irene Galani, Athens, GR
- Helen Giamarellou, Athens, GR
- Vivi Miriagou, Athens, GR
- Diamantis Plachouras, Athens, GR
- Laurent Poirel, Paris, FR
- Garyphallia Poulakou, Athens, GR
- Gian Maria Rossolini, Siena, IT
- Maria Souli, Athens, GR
- Athanassios Tsakris, Athens, GR
- Alkis Vatopoulos, Athens, GR
Contact Person
Helen Giamarellou
Phone +30 2106867946
Fax +30 2106867377
Administartive Secretariat
Imagine Congress and Travel
Mrs Vanna Antonopoulou & Mrs Christina Luthi
Kolokotroni str 9
10562 Athens, Greece
Tel +30 210 3252520
Fax +30210 3252530
Course Objectives
The course participants will be able to:
- Review the current knowledge on epidemiology of carbapenemase-producers.
- Recognise or suspect Carbapenemase-producing microorganisms at the laboratory level and proceed to further identification.
- Understand and support the infection control issues which will prevent the spread of carbapenemase-producing microorganisms in their institutions.
- Discuss treatment options against carbapenemase-producing pathogens as well as the appropriate antibiotic stewardship.
Target Audience
60 - 100 infectious disease physicians and clinical microbiologists